Comparison of HER2/neuStatus Assessed by Quantitative Polymerase Chain Reaction and Immunohistochemistry
Authors:
- Frances P. O’mAlleyFOFrances P. O’mAlley
- Robert ParkesRPRobert Parkes
- Suzanna TjanSTSuzanna Tjan
- Tanya ZadroTZTanya Zadro
- Nona ArnesonNANona Arneson
Open Access
- 1 April 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 115 (4) , 504-511
Abstract
We prospectively evaluated a series of 254 breast cancers by quantitative polymerase chain reaction (PCR) and immunohistochemistry using 3 antibodiesKeywords
This publication has 16 references indexed in Scilit:
- Specificity of HercepTest in Determining HER-2/neu Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring SystemJournal of Clinical Oncology, 1999
- Osteopontin expression in a group of lymph node negative breast cancer patientsInternational Journal of Cancer, 1998
- erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancerHuman Pathology, 1996
- The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 casesBreast Cancer Research and Treatment, 1995
- Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixationThe Journal of Pathology, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- c-erbB-2 oncoprotein expression in primary and advanced breast cancerBritish Journal of Cancer, 1991
- Long‐term survival in breast cancer related to overexpression of the c‐erbB‐2 oncoprotein: An immunohistochemical study using monoclonal antibody NCL‐CB11The Journal of Pathology, 1991